Last reviewed · How we verify
Reference001 type II — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Reference001 type II (Reference001 type II) — Sun Pharma Advanced Research Company Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Reference001 type II TARGET | Reference001 type II | Sun Pharma Advanced Research Company Limited | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Reference001 type II CI watch — RSS
- Reference001 type II CI watch — Atom
- Reference001 type II CI watch — JSON
- Reference001 type II alone — RSS
Cite this brief
Drug Landscape (2026). Reference001 type II — Competitive Intelligence Brief. https://druglandscape.com/ci/reference001-type-ii. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab